Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screen.
Sign Up to like & getrecommendations! Published in 2020 at "Briefings in bioinformatics"
DOI: 10.1093/bib/bbaa295
Abstract: Almost all currently approved systemic therapies for hepatocellular carcinoma (HCC) failed to achieve satisfactory therapeutic effect. Exploring tailored treatment strategies for different individuals provides an approach with the potential to maximize clinical benefit. Previously, multiple… read more here.
Keywords: subclass specific; hepatocellular carcinoma; drug; exploring subclass ... See more keywords